9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Estimated reading time: < 1 min

Condition: Lung Cancer

Estimated Enrollment: 20

Gender: All

Min Age: 20 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: ,  ,  ,

Interventions: lung tumor associated antigen, DetoxPC

Phase:

Study Type: Interventional

Study Design: Primary Purpose: Treatment, , ,

Primary Completion Date: June 1998

Completion Date: November 2000

Last  Posted Date: March 7, 2011

Location: Roswell Park Cancer Institute, Buffalo, New York, United States

Website Link: https://ClinicalTrials.gov/show/NCT00003974

Was this article helpful?
Dislike 0